Clinical Trial Update: The Effect of Paliperidone Palmitate in Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating paliperidone palmitate for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Invega Trinza (paliperidone palmitate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED